New horizons in the treatment of cystic fibrosis-Reference-Cited by-同舟云学术

New horizons in the treatment of cystic fibrosis

Published:2011-04-06 Issue:1 Volume:163 Page:173-183
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Cuthbert AW

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.2010.01137.x/fullpdf

Reference73 articles.

1. Interim results of a phase 2a study of VX-770 to evaluate safety, pharmacokinetics and biomarkers of CFTR activity in cystic fibrosis subjects with G551D;Accurso;Pediatr Pulmonol Suppl,2008

2. Increase in intracellular Cl- concentration by cAMP and Ca2+-dependent stimulation of M1 collecting duct cells;Adam;Eur J Physiol,2005

3. Guide to receptors and channels (GRAC), 4th edn;Alexander;Br J Pharmacol,2009

4. Bioelectric properties of proximal bronchiolar epithelium;Ballard;Am J Physiol,1994

5. CFTR involvement in chloride, bicarbonate, and liquid secretion by airway submucosal glands;Ballard;Am J Physiol,1999

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal microbial and molecular dynamics in the cystic fibrosis lung after Elexacaftor–Tezacaftor–Ivacaftor therapy;Respiratory Research;2023-12-16

2. Lung ultrasound evaluation in people with cystic fibrosis: A new approach in the pulmonology outpatient clinic;Pediatric Pulmonology;2023-11-28

3. Engineered mRNA Delivery Systems for Biomedical Applications;Advanced Materials;2023-10-08

4. Longitudinal Microbial and Molecular Dynamics in the Cystic Fibrosis Lung after Elexacaftor-Tezacaftor-Ivacaftor therapy;2023-09-25

5. The Role of MMPs in the Era of CFTR Modulators: An Additional Target for Cystic Fibrosis Patients?;Biomolecules;2023-02-10